PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2013; 8(8): e70889.
Published online Aug 6, 2013. doi:  10.1371/journal.pone.0070889
PMCID: PMC3735503
Analysis of Herpes Simplex Virion Tegument ICP4 Derived from Infected Cells and ICP4-Expressing Cells
Suzanne M. Pritchard,1 Cristina W. Cunha,1,2 and Anthony V. Nicola1,3*
1Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America
2Animal Disease Research Unit, USDA-Agricultural Research Service, Pullman, Washington, United States of America
3Paul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, United States of America
Karen L. Mossman, Editor
McMaster University, Canada
* E-mail: nicola/at/vetmed.wsu.edu
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: SP CWC AVN. Performed the experiments: SP. Analyzed the data: SP AVN. Contributed reagents/materials/analysis tools: CWC. Wrote the paper: AVN.
Received February 1, 2013; Accepted June 24, 2013.
ICP4 is the major transcriptional regulatory protein of herpes simplex virus (HSV). It is expressed in infected cells with immediate early kinetics and is essential for viral growth. ICP4 is also a structural component of the virion tegument layer. Herpesviral tegument proteins exert regulatory functions important for takeover of the host cell. Tegument ICP4 has not been well characterized. We examined the ICP4 present in HSV-1 virions that were either derived from wild type infected cells or from ICP4-expressing (E5) cells infected with ICP4 deletion virus d120. Limited proteolysis demonstrated that virion-associated ICP4 from particles derived from E5 cells was indeed an internal component of the virion. A similar subset of virion structural proteins was detected in viral particles regardless of the cellular origin of ICP4. Genotypically ICP4-negative virions complemented with tegument ICP4 entered cells via a proteasome-dependent, pH-dependent pathway similar to wild type virions. In infected cells, ICP4 was distributed predominantly in intranuclear replication compartments regardless of whether it was expressed from a transgene or from the HSV genome.
The herpes simplex virus (HSV) DNA genome is housed in an icosahedral capsid surrounded by an asymmetrical tegument layer and a surface envelope [1]. The tegument contains >19 HSV-encoded proteins and trace amounts of host cell proteins [2]. Herpesvirus tegument components mediate critical processes during the viral life cycle including viral gene expression, capsid transport to and from the nucleus, and acquisition of the virion envelope. During lytic replication, HSV expresses its genes in an orderly cascade. Immediate early (IE) proteins are critical for the expression of the subsequent early (E) and late (L) genes [1].
The viral IE regulatory proteins ICP0 and ICP4 are abundantly expressed in the infected cell [1]. They are also present in the virion tegument layer at 100–200 copies each [3], [4], [5], [6], [7], [8], [9], [10], [11]. Capsid-associated ICP0 has been proposed to regulate transport of the subviral particle to the nucleus during viral entry [10]. Little is known about ICP4 that is brought into the cell with the entering virion. ICP4 is a 175 kiloDalton DNA-binding phosphoprotein that is required for activation of E and L genes [12], [13]. In infected cells at late times post-infection, ICP4 localizes to defined intranuclear compartments where it interacts with components of the cellular RNA polymerase II transcriptional machinery to either activate or repress transcription [14], [15], [16], [17], [18]. ICP4 is absolutely essential for HSV infection, and consequently, viruses that are deleted for ICP4, such as d120 [19], must be propagated on ICP4-expressing cells, such as the complementing Vero cell line E5 [20]. Much of our understanding of ICP4 function in HSV infection is based on studies of ICP4-null viruses derived from infected ICP4-expressing cells. In an effort to better understand ICP4 associated with viral particles, we compared tegument ICP4 that originates from the ICP4 complementing cell line E5 with tegument ICP4 derived from infection of Vero cells.
Cells and Viruses
Vero and U2OS cells (American Type Culture Collection, Rockville, MD) were propagated in Dulbecco modified Eagle medium (Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine serum (Gemini Bio-Products, West Sacramento, CA). CHO-nectin-1 (M3A) cells [21] (kindly provided by Roselyn Eisenberg and Gary Cohen, University of Pennsylvania) are a hamster cell line derived from the parental CHO-K1 hamster cell line. CHO-nectin-1 cells are stably transformed with the human nectin-1 gene and the Escherichia coli lacZ gene under the control of the HSV ICP4 promoter [21]. The cells were propagated in Ham F-12 nutrient mixture (Invitrogen) supplemented with 10% fetal bovine serum, 150 µg of puromycin (Sigma, St. Louis, MO)/ml, and 250 µg of G418 sulfate (Fisher Scientific, Fair Lawn, NJ)/ml. Cells were subcultured in nonselective medium prior to use in experiments.
Wild type HSV-1 strain KOS was provided by Priscilla Schaffer (Harvard University). HSV-1 KOS mutant d120, containing a 4.1-kb deletion in both copies of the ICP4 gene [19], and the Vero-derived, complementing cell line E5 [20] were kindly provided by Neal DeLuca (University of Pittsburgh, PA). Stocks of d120 virus were propagated on E5 cells. Wild-type Glasgow strain 17 syn+ (17+) [22] and its ICP0 deletion mutant derivative dl1403 [23] were provided by R. Everett, MRC Virology Unit, Glasgow. 17+ and dl1403 were propagated and titered on U2OS cells.
SDS-PAGE and Western Blot Analysis of Virions
Extracellular HSV-1 virions were prepared by infecting Vero cells grown to 90% confluence with HSV-1 KOS or d120 at a multiplicity of infection (MOI) of 0.01. After detection of significant cytopathic effect but prior to complete detachment of the cell monolayer, the virus-containing medium was collected and spun at 1,400×g to remove cell debris. Where indicated, supernatant was layered onto a 5% sucrose cushion, and virions were pelleted by centrifugation for 1 h at 27,000×g. Samples in Laemmli buffer were separated by SDS polyacrylamide gel (4–20% gradient) electrophoresis. Gels were blotted onto nitrocellulose and probed with 1 µg of mouse monoclonal antibody (MAb)/ml specific for gB, ICP4, VP5 (MAbs H1359; Virusys, Sykesville, MD, HA018, H1A021; Santa Cruz, respectively), ICP0 (MAb 11060; Virusys) or 0.01 µg/ml MAb 1–21 to VP16 (Santa Cruz). Rabbit monoclonal antibody to Rab7 (MAb 9367; Cell Signaling Technology, Danvers, MA) was used at 1[ratio]2000. Anti-HSV rabbit polyclonal antibody (HR50; Fitzgerald Industries, Acton, MA) was added at 25 µg/ml. Nitrocellulose membranes were incubated with horseradish peroxidase-conjugated goat secondary antibody (Pierce, Rockford, IL), developed with enhanced chemiluminescence detection reagents (Pierce), and exposed to X-ray film (Kodak).
Limited Proteolysis of HSV Particles
To investigate the location of viral proteins relative to virions, extracellular HSV-1 KOS or d120 virions were treated with various concentrations of Proteinase K (Sigma) for 15 min on ice. To halt proteolysis, warmed Laemmli buffer was added, and reactions were boiled for 10 min. Samples were analyzed by 4–20% SDS-PAGE and Western blotting.
Immunofluorescence Microscopy
Virus was added to cell monolayers grown on glass coverslips in 24-well culture dishes at an MOI of 5. At 6 hr post-infection, cultures were fixed in ice-cold methanol and blocked with 1% BSA. 1 µg/ml anti-ICP4 MAb H1A021 was added followed by Alexa 488-labeled goat anti-mouse IgG (Invitrogen). Images were captured with an EVOS FL fluorescence microscope (Life Technologies).
Treatments with Proteasome Inhibitor or Lysosomotropic Agents
MG132 (75 µM; Sigma) and monensin (75 µM; Sigma) stock solutions were prepared in dimethyl sulfoxide and ethanol, respectively, and stored at 20°C. 1.5 M stock solution of ammonium chloride (Sigma) was prepared in water immediately prior to use. Confluent CHO-nectin-1 cell monolayers were grown in 96-well dishes. Growth medium was removed from cells and replaced with medium containing agents or medium containing control concentrations of dimethyl sulfoxide or ethanol. Cultures were incubated for 15 to 30 min at 37°C. Virus was added, and cells were incubated in the constant presence of agent for 6 to 7 h. Entry was measured by beta-galactosidase assay.
Beta-galactosidase Reporter Assay for HSV Entry
Following infection, 0.5% Nonidet P-40 (Sigma) cell lysates were prepared. Chlorophenol red-beta-D-galactopyranoside (Roche Diagnostic, Indianapolis, IN) was added, and the beta-galactosidase activity was read at 595 nm with an ELx808 microtiter plate reader (BioTek Instruments, Winooski, VT). Beta-galactosidase activity indicated successful entry. Mean results and standard deviations were calculated for four replicate samples. Each experiment was performed at least three times with similar results.
ICP4 is Incorporated into the Tegument of Virions Lacking the ICP4 Gene
Functional studies of virion proteins are facilitated by the ability to generate viral particles that lack the gene of interest and the protein for which it encodes. For example, functional analysis of tegument ICP0 was made possible by obtaining mutant viral particles that lack virion ICP0 [7]. Infection of cells with an ICP0 deletion mutant virus yields genotypically null virions that also lack tegument ICP0. This is possible due to the dispensable nature of the ICP0 gene at high MOI [24].
ICP4 is essential for replication, and genotypically null virions must be propagated on a cell that provides ICP4. E5 cells contain the ICP4 gene under the control of the ICP4 promoter, so ICP4 expression is induced upon infection [20]. To determine whether HSV-1 d120 propagated on ICP4-expressing cells is truly complemented with tegument ICP4, the mutant virions were analyzed. Approximately similar amounts of d120 particles as determined by Western blotting with antibody against VP5 (Fig. 1A) were examined. Relative to VP5, levels of ICP4 similar to those of wild type KOS virions were found associated with d120 virions and a ~ 40 kiloDalton ICP4 fragment was detected as reported previously [25]. To begin to address whether ICP4 is present in d120 virion preparations as a cellular contaminant due to ICP4 overexpression by the E5 cells, we probed for the host cell protein Rab7. KOS and d120 virions did not contain detectable levels of Rab7 as determined by Western blot (Fig. 1B). The same was true for longer exposures to film (not shown). As expected, Rab7 was detected in Vero and E5 cells (Fig. 1B).
Figure 1
Figure 1
Detection and localization of ICP4 in HSV-1 d120 virions propagated on ICP4 complementing cell line E5.
To probe further whether ICP4 was peripherally associated with d120 particles or whether it was present inside of the particles, limited proteolysis of HSV-1 d120 was performed. Proteinase K treatment of both d120 and wild type KOS virions resulted in a similar pattern of ICP4 proteolysis. Partial proteolysis was observed at 1 µg/ml Proteinase K, and virtually complete digestion of full length (175 kiloDalton) ICP4 was observed at 2 µg/ml (Fig. 1C). A control tegument protein, VP16, from either d120 or KOS virions was similarly susceptible to Proteinase K (Fig. 1C), thus the ICP4 associated with d120 virions is present in the particle interior. The virion-associated ICP4 in d120 particles is indeed tegument ICP4, and not the result of contaminating exogenous ICP4 from the E5 cells.
The results suggest that ICP4 expressed from a transgene is incorporated into assembling progeny virions, possibly the tegument. In this regard, virion ICP4 is distinct from virion ICP0. ICP0-null viruses grown on ICP0-expressing cells do not contain tegument ICP0 (unpublished data). This may be due to cell-expressed ICP0 localizing to the nucleus instead of the cytoplasm, which is the site of ICP0 incorporation into progeny virions. The subcellular site of ICP4 recruitment to the virion tegument and whether ICP4 is appropriately localized in E5 cells for proper tegumentation are open questions. To begin to address these issues, we next analyzed the subcellular distribution of ICP4 in ICP4-expressing E5 cells infected with either wild type or ICP4-deletion viruses.
Localization of ICP4 in HSV-infected Complementing Cells
The distribution of ICP4 in a complementing cell line was examined by immunofluorescence microscopy of infected cells. Detectable fluorescence could come from tegument-derived ICP4, newly synthesized ICP4, and/or the cell (in E5 cells). Vero cells were infected with HSV-1 d120 at an MOI of 5 for 6 hr. ICP4 fluorescence above background was not observed, indicating that input tegument ICP4 was not detectable under these experimental conditions (Fig. 2A). When E5 cells were infected with KOS or d120, ICP4 fluorescence was present predominantly in intranuclear globular replication compartments (Fig. 2C and D). More diffuse, pinpoint nuclear staining of ICP4 was detected in some E5 cells (Fig. 2C and D). This pattern resembles the intranuclear staining for ICP4 in KOS-infected Vero cells at earlier times post-infection prior to the formation of the larger replication compartments [15]. ICP4-specific fluorescence was also detected in the cytoplasm of E5 cells. Dual expression of ICP4 protein from viral and cellular sources (Fig. 2D) results in ICP4 distribution that does not differ greatly from that of wild type-infected Vero cells (Fig. 2B and [14]). The ICP4 fluorescence detected in HSV-1 d120-infected E5 cells (Fig. 2C) suggests that ICP4 derived solely from the cellular transgene exhibits wild type subcellular localization. The number of ICP4-positive cells decreased with an MOI of <1 (data not shown). Taken together the results suggest that ICP4 is properly localized in E5-infected cells (Fig. 2C) to allow for successful assembly into the tegument of progeny virions, consistent with wild type levels of incorporation of ICP4 into d120 particles (Fig. 1A).
Figure 2
Figure 2
Subcellular distribution of ICP4 in ICP4-expressing cells infected with wild type or d120 virus.
Protein Composition of HSV ICP4 Mutant Virions Propagated on ICP4-expressing Cells
We investigated whether ICP4 that was expressed from E5 cells and incorporated into tegument (as in Fig. 1) influences the protein composition of mature extracellular virions. Equivalent VP5 units of virions of parental virus HSV-1 KOS or virions of ICP4 null mutant d120 were analyzed by SDS-PAGE followed by Western blotting. The ladder of KOS structural proteins that were detectable by the anti-HSV polyclonal antibody was also detected in d120 (Fig. 3A). To examine specific representative proteins, equivalent VP5 units of extracellular virions were immunoblotted. Levels of gB and VP16 did not appear to be reduced in the d120 particles (Fig. 3B), but interestingly there was a reproducible increase in the amount of ICP0 in d120 relative to wild type virions. Thus, tegumentation of d120 capsids in ICP4-expressing cells may result in an increased incorporation of ICP0. This is consistent with previous reports of cells infected with ICP4 mutant viruses having ICP0 predominantly in the cytoplasm, the site of its incorporation [14], [26], [27]. Notably, the absence of tegument ICP0 from HSV particles does not affect the levels of ICP4 incorporated [7]. Based solely on the analysis in Figure 3, we cannot rule out that one or more structural proteins may be present in KOS virions but missing from the d120 virions or vice-versa. However, for the HSV proteins analyzed, except ICP0, the content of virions released from E5 cells was not grossly altered relative to wild type virions.
Figure 3
Figure 3
Examination of protein content of HSV-1 d120 virions.
Proteasome dependence of entry of HSV containing tegument ICP4 from distinct sources
ICP4 expressed in HSV-infected cells as an IE protein has a well-characterized, essential role in viral replication [13]. No function has been ascribed to ICP4 that is present in the virion tegument. Tegument ICP0 appears to play a novel role compared to its cell-expressed IE counterpart in infected cells. During viral entry, HSV interacts with the host cell machinery in a coordinated manner [28], [29]. Virion ICP0 may regulate incoming capsid transport to the nuclear periphery during viral entry [10]. Since ICP0 functionally cooperates with ICP4 in gene expression [30], we interrogated the role of tegument ICP4 in proteasome-dependent entry. Entry of wild type HSV is blocked by MG132, but virions lacking tegument ICP0 are more refractory to inhibition [10], [31].
Since KOS virions contain reduced levels of ICP0 relative to d120 virions (Fig. 3B), we queried whether inhibition of the proteasome would affect entry of d120 virions differently than KOS virions. Entry of d120 was inhibited by MG132 in a concentration-dependent manner similar to wild type (Fig. 4A) despite its apparently increased levels of tegument ICP0 (Fig. 3B). The entry of a mutant HSV-1 KOS that is completely devoid of tegument ICP0 is refractory to inhibition by MG132 (Fig. 4B) [10]. Virion ICP0 is capsid-associated and has been proposed to regulate the post-penetration, proteasome-dependent entry of HSV [7], [10]. One explanation for the result in Figure 4A may be that the relatively small amount of ICP0 in wild type KOS virions is sufficient to allow proteasome-dependent entry, and that the increased level of ICP0 present in d120 virions does not alter sensitivity to proteasomal inhibition. The phosphorylation state of tegument ICP4 remains to be investigated, as does whether there is a difference in ICP4 phosphorylation based on the source of the protein.
Figure 4
Figure 4
Proteasome-dependence of d120 entry into cells.
Entry Pathway taken by HSV Containing Tegument ICP4 from Distinct Sources
HSV entry requires endosomal low pH in several cell types including CHO-nectin-1 cells [32]. It has been proposed that conformational changes in gB triggered by endosomal pH lead to membrane fusion [33]. To examine whether d120 virions utilize a similar entry pathway to wild type virions, the lysosomotropic agents ammonium chloride and monensin were used to determine the pH-dependence of the HSV entry pathway. Entry of d120 into CHO-nectin-1 cells was inhibited by both pH-altering agents in a concentration-dependent manner (Fig. 5A–B). HSV-1 d120 may have an enhanced sensitivity to inhibition relative to wild type, particularly to monensin (Fig. 5B). Together the data suggest that HSV enters via a pH-dependent endocytic pathway regardless of the origin of virion ICP4.
Figure 5
Figure 5
HSV-1 d120 enters cells via an acid-dependent endocytosis pathway.
ICP4 is clearly a component of the HSV tegument layer. It is difficult to address tegument ICP4 function without first generating a viable HSV that lacks tegument ICP4. Study of tegument ICP0 has been greatly facilitated by the isolation of virions that lack ICP0 protein. Here we rigorously demonstrate that propagation of an ICP4-deletion virus on E5 cells does not result in a virus particle free of ICP4 protein. A future hypothesis to be tested is that incoming structural ICP4 regulates transcription in a manner similar to IE-expressed ICP4. Alternately, virion ICP4 may play a purely structural role with no direct function of its own. Our current strategy to generate virions devoid of ICP4 is to identify and ablate the ICP4 packaging signal. This will be difficult if there is overlap in the signal for virion incorporation and regions necessary for ICP4 function. The current study also demonstrates that the cellular origin of ICP4 does not affect its subcellular distribution, nor does it affect the proteasome-dependence or pH-dependence of entry.
Acknowledgments
We thank Mark Delboy for early contributions to the work, and Viveka Vadyvaloo and Angela Hinz for use of the fluorescence microscope. We are grateful to Gary Cohen, Roger Everett, Neal DeLuca, Roz Eisenberg, and Leigh Knodler for generous gifts of reagents.
Funding Statement
This investigation was supported by Public Health Service grants AI096103 and AI007025 from the National Institute of Allergy and Infectious Diseases and a grant from the Marvel Shields Autzen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
1. Roizman B, Knipe DM, Whitley RJ (2007) Herpes simplex viruses. In: Knipe DM, Howley PM, editors. Fields Virology: Lipincott Williams & Wilkins. 2501–2602.
2. Kelly BJ, Fraefel C, Cunningham AL, Diefenbach RJ (2009) Functional roles of the tegument proteins of herpes simplex virus type 1. Virus research 145: 173–186. [PubMed]
3. Yao F, Courtney RJ (1989) A major transcriptional regulatory protein (ICP4) of herpes simplex virus type 1 is associated with purified virions. Journal of Virology 63: 3338–3344. [PMC free article] [PubMed]
4. Yao F, Courtney RJ (1992) Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1. J Virol 66: 2709–2716. [PMC free article] [PubMed]
5. Loret S, Guay G, Lippe R (2008) Comprehensive characterization of extracellular herpes simplex virus type 1 virions. Journal of Virology 82: 8605–8618. [PMC free article] [PubMed]
6. Sedlackova L, Rice SA (2008) Herpes simplex virus type 1 immediate-early protein ICP27 is required for efficient incorporation of ICP0 and ICP4 into virions. J Virol 82: 268–277. [PMC free article] [PubMed]
7. Delboy MG, Siekavizza-Robles CR, Nicola AV (2010) Herpes simplex virus tegument ICP0 is capsid associated, and its E3 ubiquitin ligase domain is important for incorporation into virions. Journal of Virology 84: 1637–1640. [PMC free article] [PubMed]
8. Maringer K, Elliott G (2010) Recruitment of herpes simplex virus type 1 immediate-early protein ICP0 to the virus particle. Journal of Virology 84: 4682–4696. [PMC free article] [PubMed]
9. Radtke K, Kieneke D, Wolfstein A, Michael K, Steffen W, et al. (2010) Plus- and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures. PLoS pathogens 6: e1000991. [PMC free article] [PubMed]
10. Delboy MG, Nicola AV (2011) A pre-immediate early role for tegument ICP0 in the proteasome-dependent entry of herpes simplex virus. Journal of virology. [PMC free article] [PubMed]
11. Loret S, Lippe R (2012) Biochemical analysis of infected cell polypeptide (ICP)0, ICP4, UL7 and UL23 incorporated into extracellular herpes simplex virus type 1 virions. The Journal of general virology 93: 624–634. [PubMed]
12. Courtney RJ, Benyesh-Melnick M (1974) Isolation and characterization of a large molecular-weight polypeptide of herpes simplex virus type 1. Virology 62: 539–551. [PubMed]
13. DeLuca NA (2011) Functions and mechanism of action of the herpes simplex virus regulatory protein, ICP4. In: Weller SK, editor. Alphaherpesviruses: Molecular Virology. Norfolk, UK: Caister Academic Press. 17–38.
14. Knipe DM, Smith JL (1986) A mutant herpesvirus protein leads to a block in nuclear localization of other viral proteins. Molecular and cellular biology 6: 2371–2381. [PMC free article] [PubMed]
15. Knipe DM, Senechek D, Rice SA, Smith JL (1987) Stages in the nuclear association of the herpes simplex virus transcriptional activator protein ICP4. Journal of Virology 61: 276–284. [PMC free article] [PubMed]
16. Gu B, Rivera-Gonzalez R, Smith CA, DeLuca NA (1993) Herpes simplex virus infected cell polypeptide 4 preferentially represses Sp1-activated over basal transcription from its own promoter. Proceedings of the National Academy of Sciences of the United States of America 90: 9528–9532. [PubMed]
17. Smith CA, Bates P, Rivera-Gonzalez R, Gu B, DeLuca NA (1993) ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. Journal of Virology 67: 4676–4687. [PMC free article] [PubMed]
18. Leopardi R, Ward PL, Ogle WO, Roizman B (1997) Association of herpes simplex virus regulatory protein ICP22 with transcriptional complexes containing EAP, ICP4, RNA polymerase II, and viral DNA requires posttranslational modification by the U(L)13 proteinkinase. Journal of Virology 71: 1133–1139. [PMC free article] [PubMed]
19. DeLuca NA, McCarthy AM, Schaffer PA (1985) Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 56: 558–570. [PMC free article] [PubMed]
20. DeLuca NA, Schaffer PA (1987) Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Research 15: 4491–4511. [PMC free article] [PubMed]
21. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG (1998) Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280: 1618–1620. [PubMed]
22. Brown SM, Ritchie DA, Subak-Sharpe JH (1973) Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. The Journal of general virology 18: 329–346. [PubMed]
23. Stow ND, Stow EC (1986) Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol 67 (Pt 12): 2571–2585. [PubMed]
24. Cai W, Schaffer PA (1992) Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. Journal of Virology 66: 2904–2915. [PMC free article] [PubMed]
25. Su YH, Zhang X, Wang X, Fraser NW, Block TM (2006) Evidence that the immediate-early gene product ICP4 is necessary for the genome of the herpes simplex virus type 1 ICP4 deletion mutant strain d120 to circularize in infected cells. Journal of Virology 80: 11589–11597. [PMC free article] [PubMed]
26. Zhu Z, Cai W, Schaffer PA (1994) Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. Journal of Virology 68: 3027–3040. [PMC free article] [PubMed]
27. Zhu Z, DeLuca NA, Schaffer PA (1996) Overexpression of the herpes simplex virus type 1 immediate-early regulatory protein, ICP27, is responsible for the aberrant localization of ICP0 and mutant forms of ICP4 in ICP4 mutant virus-infected cells. Journal of Virology 70: 5346–5356. [PMC free article] [PubMed]
28. Eisenberg RJ, Atanasiu D, Cairns TM, Gallagher JR, Krummenacher C, et al. (2012) Herpes virus fusion and entry: a story with many characters. Viruses 4: 800–832. [PMC free article] [PubMed]
29. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R (2011) Fusing structure and function: a structural view of the herpesvirus entry machinery. Nature reviews Microbiology 9: 369–381. [PMC free article] [PubMed]
30. Quinlan MP, Knipe DM (1985) Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol Cell Biol 5: 957–963. [PMC free article] [PubMed]
31. Delboy MG, Roller DG, Nicola AV (2008) Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step. J Virol 82: 3381–3390. [PMC free article] [PubMed]
32. Nicola AV, McEvoy AM, Straus SE (2003) Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol 77: 5324–5332. [PMC free article] [PubMed]
33. Dollery SJ, Delboy MG, Nicola AV (2010) Low pH-induced conformational change in herpes simplex virus glycoprotein B. J Virol. 84: 3759–3766. [PMC free article] [PubMed]
Articles from PLoS ONE are provided here courtesy of
Public Library of Science